CRISPR Gene Editing Tools Market
CRISPR Gene Editing Tools Market Scope: Industry
Analysis, Market Size, Growth, Trends Till 2031
Request Sample Report
CRISPR Gene Editing Tools Market Size and Growth
The CRISPR Gene Editing Tools market exhibits significant growth, driven by advancements in biotechnology and increasing applications in therapeutics and agriculture. The market size is projected to reach USD 10 billion by 2028, driven by rising investment in research and a growing demand for precision medicine and genetic modification solutions.
Companies Covered
(Covid 19 Impact Covered)
◍ Abcam, Inc.
◍ Agilent Technologies, Inc.
◍ CRISPR Therapeutics AG
◍ GeneCopoeia, Inc.
◍ GenScript Biotech Corporation
◍ Integrated DNA Technologies, Inc.
◍ New England Biolabs, Inc.
◍ Origene Technologies, Inc.
◍ Rockland Immunochemicals, Inc.
◍ Thermo Fisher Scientific, Inc.
The CRISPR gene editing tools market features key players like Thermo Fisher Scientific, Agilent Technologies, and GenScript, providing advanced reagents and services. Their innovations drive research and commercialization, enhancing applications in therapeutics and biotechnology. Notable companies report revenues such as:
- Thermo Fisher Scientific: ~$40 billion
- Agilent Technologies: ~$6 billion
- CRISPR Therapeutics: ~$300 million
Request Sample Report
Market Segmentation
By Application
Agricultural
Biomedical
Industrial
Others
By Product
◍ Cas Nuclease
Guide RNA
DNA ligase
Restriction Endonuclease
Others
Request Sample Report
Market Growth
Request Sample Report
$ X Billion USD
